On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q2 2023 earnings per share (EPS) of $0.79, up 31.3% year over year. Total Abbott Laboratories earnings for the quarter were $1.38 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $1.15.
As of Q3 2023, Abbott Laboratories's earnings has grown -38.92% year over year. This is 36.49 percentage points lower than the US Medical Devices industry earnings growth rate of -2.43%. Abbott Laboratories's earnings in the past year totalled $5.16 billion.
What is ABT's earnings date?
Abbott Laboratories's earnings date is Invalid Date. Add ABT to your watchlist to be reminded of ABT's next earnings announcement.
What was ABT's revenue last quarter?
On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q2 2023 revenue of $9.98 billion up 11.36% year over year. In the same quarter last year, Abbott Laboratories's revenue was $11.26 billion.
What was ABT's revenue growth in the past year?
As of Q3 2023, Abbott Laboratories's revenue has grown -11.68% year over year. This is 17.51 percentage points lower than the US Medical Devices industry revenue growth rate of 5.82%. Abbott Laboratories's revenue in the past year totalled $40.23 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.